亚洲传统医药 ›› 2024, Vol. 19 ›› Issue (5): 275-284.

• • 上一篇    下一篇

A review: Research progress on multi-target neuroprotective effects of n-butylphthalide  extracted from Apium graveolens seeds #br#

  

  • 出版日期:2024-10-28 发布日期:2024-10-31

A review: Research progress on multi-target neuroprotective effects of n-butylphthalide  extracted from Apium graveolens seeds

  • Online:2024-10-28 Published:2024-10-31

摘要:

Apium graveolens, an annual herb belonging to the family of Apiaceae, is widely distributed in North and South America,  Southern Europe, Africa and Asia. Apium graveolens seeds have a rich history in traditional Chinese medicine for treating  hypertension, headaches, vertigo and epilepsy. N-butylphthalide, originally extracted from Apium graveolens seeds, represents  a first-in-class drug developed independently in China. Its broad pharmacological activities on nervous system disorders have  garnered significant attention from researchers globally. This review focuses on the pharmacological research of n-butylphthalide  on central nervous system diseases, including ischemic stroke, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral  sclerosis. The purpose is to pave the way for future study on the mechanistic targets of n-butylphthalide.

关键词: font-family:微软雅黑, Microsoft YaHei, ">color:#231F20, font-style:italic, ">Apium graveolens color:#231F20, ">seeds, color:#231F20, font-style:italic, ">ncolor:#231F20, ">-butylphthalide, central nervous system diseases

Abstract:

Apium graveolens, an annual herb belonging to the family of Apiaceae, is widely distributed in North and South America,  Southern Europe, Africa and Asia. Apium graveolens seeds have a rich history in traditional Chinese medicine for treating  hypertension, headaches, vertigo and epilepsy. N-butylphthalide, originally extracted from Apium graveolens seeds, represents  a first-in-class drug developed independently in China. Its broad pharmacological activities on nervous system disorders have  garnered significant attention from researchers globally. This review focuses on the pharmacological research of n-butylphthalide  on central nervous system diseases, including ischemic stroke, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral  sclerosis. The purpose is to pave the way for future study on the mechanistic targets of n-butylphthalide.

Key words: font-family:微软雅黑, Microsoft YaHei, ">color:#231F20, font-style:italic, ">Apium graveolens color:#231F20, ">seeds, color:#231F20, font-style:italic, ">ncolor:#231F20, ">-butylphthalide, central nervous system diseases